Clinical Trials Logo

H Pylori Eradication clinical trials

View clinical trials related to H Pylori Eradication.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03087162 Completed - Clinical trials for H Pylori Eradication

Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori

Start date: January 1, 2017
Phase: Phase 4
Study type: Interventional

New drug regimen for Helicobacter pylori eradication, the investigators compare once daily dose dexlansoprazole levofloxacin based quadruple therapy and twice daily dose dexlansoprazole levofloxacin quadruple therapy for helicobacter pylori eradication.